A Randomized Controlled Trial to Evaluate the Use of Probiotics in Prevention of Ventilator-Associated Pneumonia in Critically Ill ICU Patients

Anand Prasoon, R. Singh, R. Anand, Sanjeev Kumar, Siddharth Singh, A. Singh
{"title":"A Randomized Controlled Trial to Evaluate the Use of Probiotics in Prevention of Ventilator-Associated Pneumonia in Critically Ill ICU Patients","authors":"Anand Prasoon, R. Singh, R. Anand, Sanjeev Kumar, Siddharth Singh, A. Singh","doi":"10.1055/s-0042-1754161","DOIUrl":null,"url":null,"abstract":"\n Context Ventilator-associated pneumonia (VAP) is one of the most common causes of morbidity and mortality in mechanically ventilated patients. Curing and preventing effects of probiotics in promoting the growth of Bifidobacterium in the digestive system and the central role of bacteria colonization in the pathogenesis of VAP are evident.\n Aims The purpose of this study was to evaluate the effects of administration of commercially available probiotics, that is, orodispersible probiotic sachets on VAP prevention and clinical outcomes in critically ill patients.\n Settings and Design Randomized control trials.\n Methods and Materials In this study, 120 mechanically ventilated patients were randomly divided into two groups (n = 60 per group). Group 1 was given orodispersible probiotic sachets by gavage, twice a day in addition to routine care, while group 2 received only routine care. Demographic and clinical data were analyzed and clinical outcomes to the primary component (prevalence of VAP) and secondary component (other clinical factors) were interpreted.\n Statistical Analysis Used In this study, data were analyzed via SAS statistical software version 9.4, using Student's t-test, chi-squared test, repeated measure analysis of variance, and Wilcoxon test.\n Results There was a significant reduction in VAP diagnosed patients, as well as Clostridium\n difficile-associated diarrhea and some complications of mechanical ventilation, in group 1 in comparison to group 2. The improvement in VAP was significantly greater for group 1 as compared with group 2. However, the mortality rate was similar between two groups.\n Conclusions This study demonstrated that a daily diet with orodispersible probiotic sachets can be used as add-on therapy with other medications in the prevention of VAP. As a result, the use of orodispersible probiotic sachets in the treatment plan of patients undergoing long-term intubation is recommended.","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiac Critical Care TSS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0042-1754161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Context Ventilator-associated pneumonia (VAP) is one of the most common causes of morbidity and mortality in mechanically ventilated patients. Curing and preventing effects of probiotics in promoting the growth of Bifidobacterium in the digestive system and the central role of bacteria colonization in the pathogenesis of VAP are evident. Aims The purpose of this study was to evaluate the effects of administration of commercially available probiotics, that is, orodispersible probiotic sachets on VAP prevention and clinical outcomes in critically ill patients. Settings and Design Randomized control trials. Methods and Materials In this study, 120 mechanically ventilated patients were randomly divided into two groups (n = 60 per group). Group 1 was given orodispersible probiotic sachets by gavage, twice a day in addition to routine care, while group 2 received only routine care. Demographic and clinical data were analyzed and clinical outcomes to the primary component (prevalence of VAP) and secondary component (other clinical factors) were interpreted. Statistical Analysis Used In this study, data were analyzed via SAS statistical software version 9.4, using Student's t-test, chi-squared test, repeated measure analysis of variance, and Wilcoxon test. Results There was a significant reduction in VAP diagnosed patients, as well as Clostridium difficile-associated diarrhea and some complications of mechanical ventilation, in group 1 in comparison to group 2. The improvement in VAP was significantly greater for group 1 as compared with group 2. However, the mortality rate was similar between two groups. Conclusions This study demonstrated that a daily diet with orodispersible probiotic sachets can be used as add-on therapy with other medications in the prevention of VAP. As a result, the use of orodispersible probiotic sachets in the treatment plan of patients undergoing long-term intubation is recommended.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一项评估益生菌预防重症ICU患者呼吸机相关性肺炎的随机对照试验
呼吸机相关性肺炎(VAP)是机械通气患者发病和死亡的最常见原因之一。益生菌在促进消化系统双歧杆菌生长中的治疗和预防作用以及细菌定植在VAP发病机制中的核心作用是显而易见的。本研究的目的是评估市售益生菌(即可分散益生菌包)对危重患者VAP预防和临床结果的影响。设置与设计随机对照试验。方法与材料本研究将120例机械通气患者随机分为两组,每组60例。组1在常规护理的基础上给予益生菌微囊灌胃,每日2次;组2仅给予常规护理。对人口统计学和临床数据进行分析,并对主要成分(VAP患病率)和次要成分(其他临床因素)的临床结果进行解释。本研究采用SAS 9.4版统计软件对数据进行分析,采用Student’st检验、卡方检验、重复测量方差分析和Wilcoxon检验。结果与2组相比,1组VAP诊断患者、艰难梭菌相关性腹泻和一些机械通气并发症显著减少。1组VAP的改善明显大于2组。然而,两组之间的死亡率相似。结论本研究表明,每日饮食中添加或分散的益生菌包可作为其他药物预防VAP的补充治疗。因此,建议在长期插管患者的治疗方案中使用可分散的益生菌小袋。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
25
审稿时长
21 weeks
期刊最新文献
Prognostic Cardiac Biomarkers and Tetralogy of Fallot Score: Do they Predict Outcomes in Intracardiac Tetralogy of Fallot Repair? The Anesthesiologist as Extracorporeal Membrane Oxygenation Intensivist: Heralding a New Era? Extracorporeal Membrane Oxygenation Nursing Care A Bibliometric Study on Junctional Ectopic Tachycardia: Time and Trends have much to Tell! Evaluation of Right Ventricular Function in Patients Undergoing Mitral Valve Replacement with Pulmonary Artery Systolic Pressure of more than 50 mmHg: A Prospective Analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1